Exact Mass: 434.2093
Exact Mass Matches: 434.2093
Found 500 metabolites which its exact mass value is equals to given mass value 434.2093
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dexamethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3264 CONFIDENCE standard compound; INTERNAL_ID 2835
Extracort
CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8728; ORIGINAL_PRECURSOR_SCAN_NO 8723 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8791; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8741; ORIGINAL_PRECURSOR_SCAN_NO 8739 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8700; ORIGINAL_PRECURSOR_SCAN_NO 8699 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8788; ORIGINAL_PRECURSOR_SCAN_NO 8786 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8777; ORIGINAL_PRECURSOR_SCAN_NO 8775 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents CONFIDENCE standard compound; INTERNAL_ID 2826 D000893 - Anti-Inflammatory Agents
Flunisolide
Flunisolide is only found in individuals that have used or taken this drug. It is a corticosteroid often prescribed as treatment for allergic rhinitis.Flunisolide is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flunisolide binds to plasma transcortin, and it becomes active when it is not bound to transcortin. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents CONFIDENCE standard compound; INTERNAL_ID 2812 D000893 - Anti-Inflammatory Agents
Paramethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D01229
9alpha-Fluoro-6alpha-methylprednisolone 21-acetate
1,1'-Ethylidenebistryptophan
Impurity in synthetic L-tryptophan, linked to an outbreak of fatal eosinophilia myalgia syndrome in 1989 associated with dietary supplements containing tryptophan Impurity in synthetic L-tryptophan, linked to an outbreak of fatal eosinophilia myalgia syndrome in 1989 associated with dietary supplements containing tryptopha
4,5-Dihydro-drospirenone-3-sulfate
4,5-Dihydro-drospirenone-3-sulfate is a metabolite of drospirenone. Drospirenone, also known as 1,2-dihydrospirorenone, is synthetic, steroidal progestin with additional antimineralocorticoid and weak antiandrogen properties which is used as a hormonal contraceptive. It is sold under the brand names Yasmin, Yasminelle, Yaz, Beyaz, Ocella, and Angeliq, all of which are combination products of drospirenone with an estrogen such as ethinylestradiol. (Wikipedia)
Dexamethasone acetate
Paramethasone acetate
(E)-7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-3-(4-hydroxyphenethyl) isocoumarin|Achlisocoumarin I
rel-(7R,8R,7S,8R)-3,4,4-trihydroxy-3-[1-methyl-2-(4-hydroxyphenyl)]ethyl-7,7-epoxylignan|ribesin G
8-(3,4-Dihydro-5-methoxy-6,8,8-trimethyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-3-yl)-2,2-dimethyl-2H-1-benzopyran-5-ol
(2R,3R,4R,5S,6S)-3,4,5-Tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-ol
(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran<2,3:7,8>flavanone
Betamethasone Acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2032 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3244
Triamcinolone acetonide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents
Ala Ala His His
Ala Cys Lys Asn
Ala Cys Asn Lys
Ala Phe Pro Thr
Ala Phe Thr Pro
Ala His Ala His
Ala His His Ala
Ala Ile Met Thr
Ala Ile Thr Met
Ala Lys Cys Asn
Ala Lys Asn Cys
Ala Leu Met Thr
Ala Leu Thr Met
Ala Met Ile Thr
Ala Met Leu Thr
Ala Met Thr Ile
Ala Met Thr Leu
Ala Asn Cys Lys
Ala Asn Lys Cys
Ala Pro Phe Thr
Ala Pro Thr Phe
Ala Thr Phe Pro
Ala Thr Ile Met
Ala Thr Leu Met
Ala Thr Met Ile
Ala Thr Met Leu
Ala Thr Pro Phe
Cys Ala Lys Asn
Cys Ala Asn Lys
Cys Gly Lys Gln
Cys Gly Gln Lys
Cys Ile Ile Ser
Cys Ile Leu Ser
Cys Ile Ser Ile
Cys Ile Ser Leu
Cys Ile Thr Val
Cys Ile Val Thr
Cys Lys Ala Asn
Cys Lys Gly Gln
Cys Lys Asn Ala
Cys Lys Gln Gly
Cys Leu Ile Ser
Cys Leu Leu Ser
Cys Leu Ser Ile
Cys Leu Ser Leu
Cys Leu Thr Val
Cys Leu Val Thr
Cys Asn Ala Lys
Cys Asn Lys Ala
Cys Ser Ile Ile
Cys Ser Ile Leu
Cys Ser Leu Ile
Cys Ser Leu Leu
Cys Thr Ile Val
Cys Thr Leu Val
Cys Thr Val Ile
Cys Thr Val Leu
Cys Val Ile Thr
Cys Val Leu Thr
Cys Val Thr Ile
Cys Val Thr Leu
Asp Ile Ser Thr
Asp Ile Thr Ser
Asp Leu Ser Thr
Asp Leu Thr Ser
Asp Ser Ile Thr
Asp Ser Leu Thr
Asp Ser Thr Ile
Asp Ser Thr Leu
Asp Thr Ile Ser
Asp Thr Leu Ser
Asp Thr Ser Ile
Asp Thr Ser Leu
Asp Thr Thr Val
Asp Thr Val Thr
Asp Val Thr Thr
Glu Ile Ser Ser
Glu Leu Ser Ser
Glu Ser Ile Ser
Glu Ser Leu Ser
Glu Ser Ser Ile
Glu Ser Ser Leu
Glu Ser Thr Val
Glu Ser Val Thr
Glu Thr Ser Val
Glu Thr Val Ser
Glu Val Ser Thr
Glu Val Thr Ser
Phe Ala Pro Thr
Phe Ala Thr Pro
Phe Pro Ala Thr
Phe Pro Thr Ala
Phe Thr Ala Pro
Phe Thr Pro Ala
Gly Pro Val Tyr
Gly Pro Tyr Val
Gly Val Pro Tyr
Gly Val Tyr Pro
Gly Tyr Pro Val
Gly Tyr Val Pro
His Ala Ala His
His Ala His Ala
His His Ala Ala
Ile Ala Met Thr
Ile Ala Thr Met
Ile Cys Ile Ser
Ile Cys Leu Ser
Ile Cys Ser Ile
Ile Cys Ser Leu
Ile Cys Thr Val
Ile Cys Val Thr
Ile Asp Ser Thr
Ile Asp Thr Ser
Ile Glu Ser Ser
Ile Ile Cys Ser
Ile Ile Ser Cys
Ile Leu Cys Ser
Ile Leu Ser Cys
Ile Met Ala Thr
Ile Met Thr Ala
Ile Ser Cys Ile
Ile Ser Cys Leu
Ile Ser Asp Thr
Ile Ser Glu Ser
Ile Ser Ile Cys
Ile Ser Leu Cys
Ile Ser Ser Glu
Ile Ser Thr Asp
Ile Thr Ala Met
Ile Thr Cys Val
Ile Thr Asp Ser
Ile Thr Met Ala
Ile Thr Ser Asp
Ile Thr Val Cys
Ile Val Cys Thr
Ile Val Thr Cys
Lys Asn Ser Ser
Lys Ser Asn Ser
Lys Ser Ser Asn
Leu Ala Met Thr
Leu Ala Thr Met
Leu Cys Ile Ser
Leu Cys Leu Ser
Leu Cys Ser Ile
Leu Cys Ser Leu
Leu Cys Thr Val
Leu Cys Val Thr
Leu Asp Ser Thr
Leu Asp Thr Ser
Leu Glu Ser Ser
Leu Ile Cys Ser
Leu Ile Ser Cys
Leu Leu Cys Ser
Leu Leu Ser Cys
Leu Met Ala Thr
Leu Met Thr Ala
Leu Ser Cys Ile
Leu Ser Cys Leu
Leu Ser Asp Thr
Leu Ser Glu Ser
Leu Ser Ile Cys
Leu Ser Leu Cys
Leu Ser Ser Glu
Leu Ser Thr Asp
Leu Thr Ala Met
Leu Thr Cys Val
Leu Thr Asp Ser
Leu Thr Met Ala
Leu Thr Ser Asp
Leu Thr Val Cys
Leu Val Cys Thr
Leu Val Thr Cys
Met Ala Ile Thr
Met Ala Leu Thr
Met Ala Thr Ile
Met Ala Thr Leu
Met Ile Ala Thr
Met Ile Thr Ala
Met Leu Ala Thr
Met Leu Thr Ala
Met Ser Val Val
Met Thr Ala Ile
Met Thr Ala Leu
Met Thr Ile Ala
Met Thr Leu Ala
Met Val Ser Val
Met Val Val Ser
Asn Lys Ser Ser
Asn Ser Lys Ser
Asn Ser Ser Lys
Pro Ala Phe Thr
Pro Ala Thr Phe
Pro Phe Ala Thr
Pro Phe Thr Ala
Pro Gly Val Tyr
Pro Gly Tyr Val
Pro Thr Ala Phe
Pro Thr Phe Ala
Pro Val Gly Tyr
Pro Val Tyr Gly
Pro Tyr Gly Val
Pro Tyr Val Gly
Ser Cys Ile Ile
Ser Cys Ile Leu
Ser Cys Leu Ile
Ser Cys Leu Leu
Ser Asp Ile Thr
Ser Asp Leu Thr
Ser Asp Thr Ile
Ser Asp Thr Leu
Ser Glu Ile Ser
Ser Glu Leu Ser
Ser Glu Ser Ile
Ser Glu Ser Leu
Ser Glu Thr Val
Ser Glu Val Thr
Ser Ile Cys Ile
Ser Ile Cys Leu
Ser Ile Asp Thr
Ser Ile Glu Ser
Ser Ile Ile Cys
Ser Ile Leu Cys
Ser Ile Ser Glu
Ser Ile Thr Asp
Ser Lys Asn Ser
Ser Lys Ser Asn
Ser Leu Cys Ile
Ser Leu Cys Leu
Ser Leu Asp Thr
Ser Leu Glu Ser
Ser Leu Ile Cys
Ser Leu Leu Cys
Ser Leu Ser Glu
Ser Leu Thr Asp
Ser Met Val Val
Ser Asn Lys Ser
Ser Asn Ser Lys
Ser Ser Glu Ile
Ser Ser Glu Leu
Ser Ser Ile Glu
Ser Ser Lys Asn
Ser Ser Leu Glu
Ser Ser Asn Lys
Ser Thr Asp Ile
Ser Thr Asp Leu
Ser Thr Glu Val
Ser Thr Ile Asp
Ser Thr Leu Asp
Ser Thr Val Glu
Ser Val Glu Thr
Ser Val Met Val
Ser Val Thr Glu
Ser Val Val Met
Thr Ala Phe Pro
Thr Ala Ile Met
Thr Ala Leu Met
Thr Ala Met Ile
Thr Ala Met Leu
Thr Ala Pro Phe
Thr Cys Ile Val
Thr Cys Leu Val
Thr Cys Val Ile
Thr Cys Val Leu
Thr Asp Ile Ser
Thr Asp Leu Ser
Thr Asp Ser Ile
Thr Asp Ser Leu
Thr Asp Thr Val
Thr Asp Val Thr
Thr Glu Ser Val
Thr Glu Val Ser
Thr Phe Ala Pro
Thr Phe Pro Ala
Thr Ile Ala Met
Thr Ile Cys Val
Thr Ile Asp Ser
Thr Ile Met Ala
Thr Ile Ser Asp
Thr Ile Val Cys
Thr Leu Ala Met
Thr Leu Cys Val
Thr Leu Asp Ser
Thr Leu Met Ala
Thr Leu Ser Asp
Thr Leu Val Cys
Thr Met Ala Ile
Thr Met Ala Leu
Thr Met Ile Ala
Thr Met Leu Ala
Thr Pro Ala Phe
Thr Pro Phe Ala
Thr Ser Asp Ile
Thr Ser Asp Leu
Thr Ser Glu Val
Thr Ser Ile Asp
Thr Ser Leu Asp
Thr Ser Val Glu
Thr Thr Asp Val
Thr Thr Val Asp
Thr Val Cys Ile
Thr Val Cys Leu
Thr Val Asp Thr
Thr Val Glu Ser
Thr Val Ile Cys
Thr Val Leu Cys
Thr Val Ser Glu
Thr Val Thr Asp
Val Cys Ile Thr
Val Cys Leu Thr
Val Cys Thr Ile
Val Cys Thr Leu
Val Asp Thr Thr
Val Glu Ser Thr
Val Glu Thr Ser
Val Gly Pro Tyr
Val Gly Tyr Pro
Val Ile Cys Thr
Val Ile Thr Cys
Val Leu Cys Thr
Val Leu Thr Cys
Val Met Ser Val
Val Met Val Ser
Val Pro Gly Tyr
Val Pro Tyr Gly
Val Ser Glu Thr
Val Ser Met Val
Val Ser Thr Glu
Val Ser Val Met
Val Thr Cys Ile
Val Thr Cys Leu
Val Thr Asp Thr
Val Thr Glu Ser
Val Thr Ile Cys
Val Thr Leu Cys
Val Thr Ser Glu
Val Thr Thr Asp
Val Val Met Ser
Val Val Ser Met
Val Tyr Gly Pro
Val Tyr Pro Gly
Tyr Gly Pro Val
Tyr Gly Val Pro
Tyr Pro Gly Val
Tyr Pro Val Gly
Tyr Val Gly Pro
Tyr Val Pro Gly
Peak E
chlorbenzoxamine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
CUDC-101
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor
2-Diphenylacetyl-3-(cyclohexyl-hydrazono)indan-1-one
2,6-ditert-butyl-4-[(6-oxobenzo[c][2,1]benzoxaphosphinin-6-yl)methyl]phenol
1-ethyl-2-[1,2,3,4-tetrahydro-1-(2-hydroxyethyl)-2,2,4-trimethyl-6-quinolyl]benz[cd]indolium chloride
2,4-diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Pyrimidine
(3-cyano-1,4-dimethyl-3-phenyl-pentyl)-dimethyl-ammonium citrate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11beta,16alpha)-
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents
Fluperolone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
1-{[1-(2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-2-(3-cyano-phenyl)-ethaneboronic acid
(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran[2,3:7,8]flavanone
An extended flavonoid that consists of (2S)-flavanone substituted methoxy groups at positions 3 and 4, a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor.
Asp-Leu-Thr-Ser
A tetrapeptide composed of L-aspartic acid, L-leucine, L-threonine and L-serine joined in sequence by peptide linkages.
2-Amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile
2-[[[4-[[(diphenylmethyl)amino]-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]acetic acid tert-butyl ester
N-[(2S,3R,6R)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
N-[(2S,3S,6R)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
N-[(2S,3S,6S)-6-[2-[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]ethyl]-2-(hydroxymethyl)oxan-3-yl]-4-fluorobenzamide
2-[(3R,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
N-[(2R,3S,6S)-6-[2-[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]ethyl]-2-(hydroxymethyl)oxan-3-yl]-4-fluorobenzamide
2-[(3R,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8R,10aS)-1-(4-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
2-[(3S,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-cyclopropyl-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-6-oxo-12-(2-phenylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(6S,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
1-[(2S,3S)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
N-[(2S,3R,6S)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
N-[(2R,3S,6R)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
N-[(2R,3R,6R)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
N-[(2R,3R,6S)-6-[2-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzamide
2-cyclopropyl-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-[(3R,6aR,8R,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[oxo(pyridin-4-yl)methyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[oxo(pyridin-4-yl)methyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
(6S,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
1-[(2R,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
1-[(2S,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
(2S,4R,10S,14S,16S,18S)-10,14-dimethyl-5-oxospiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2-oxolane]-7-sulonic acid
FLUNISOLIDE
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
BisMePA(15:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Enerisant (hydrochloride)
Enerisant (TS-091) hydrochloride is a potent, highly selective, competitive and orally active histamine H3 receptor antagonist/inverse agonist with IC50s of 2.89 nM and 14.5 nM against human and rat histamine H3 receptors, respectively[1].